Walgreens Boots Alliance is a leading global pharmacy-led, health and wellness enterprise. It has a presence in 9 countries and employs more than 325,000 people. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and well-being products. It is anchored by iconic brands, Walgreens in the U.S. and Boots in Europe and Asia, and aims to meet its customer needs through convenient retail locations, digital platforms, and health and beauty products. WBA’s retail and business brands portfolio includes Duane Reade in the U.S., Benavides in Mexico, and Ahumada in Chile. Its global beauty brands include No7, Soap & Glory, Liz Earle, Botanics, Sleek MakeUP, and YourGoodSkin. As of FY2021, the company had a total of 13,343 stores combining all domestic and international retail stores and clinics.
As of FY2021, the company closed a net of 106 stores and had a total of 13,343 stores worldwide.
The company's U.S. Retail Pharmacy segment includes the Walgreens business, which comprises the operations of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. The U.S. Retail Pharmacy segment (excluding equity method investments) has pharmacy-led health and beauty retail offerings in 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. In FY2022, the company operated 8,889 retail stores in this segment. The principal retail pharmacy brands in the segment are Walgreens and Duane Reade. The U.S. Healthcare segment included 124 standalone clinics as well.
The International segment consists of pharmacy-led health and beauty retail businesses outside the U.S. and the pharmaceutical wholesaling and distribution business in Germany, Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico, and the Ahumada brand in Chile. The company operated 4,330 retail stores in the segment during the fiscal.
On June 1, 2021, the company completed the sale of the majority of the company's Alliance Healthcare business as well as a portion of the company’s retail pharmacy international businesses in Europe (“Disposal Group”) to AmerisourceBergen Corporation. Consequently, all prior periods' operating results for the Disposal Group were reported as discontinued operations.
On September 19, 2017, the company announced that it had secured regulatory clearance for an asset purchase agreement to purchase 1,932 stores, three distribution centers, and related inventory from Rite Aid Corporation for $4.375 billion in cash and other consideration. The company completed the acquisition in FY2018. This resulted in an increase in the total store count by a net of 1,505 stores bringing the total store count to 14,327 stores in FY2018.
Also on October 24, 2017, the company approved a plan to implement the Store Optimization Program to optimize store locations through the planned closure of approximately 600 stores and related assets within the company’s Retail Pharmacy USA segment upon completion of the acquisition of certain stores and related assets from Rite Aid. The actions under the Store Optimization Program were commenced in March 2018 and completed by the end of FY2020.
United States of America
United States of America
United States of America
United States of America
United States of America
Netherlands
United States of America
Japan
United Kingdom
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer